Limited significance of activated akt-mammalian target of rapamycin signaling pathway in prostate cancer progression

Young Hwii Ko, Hideaki Miyake, Hosny M. Behnsawy, Jun Cheon, Masato Fujisawa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: The objective of this study was to investigate the significance of the activated Akt-mammalian target of rapamycin (Akt-mTOR) signaling pathway in the progression of prostate cancer. Materials and Methods: The expression levels of Akt, phosphorylated Akt (p-Akt), mTOR and phosphorylated mTOR (p-mTOR) in 175 prostate specimens, including 61 normal prostate tissues as a control, 24 high-grade prostatic intraepithelial neoplasias (HGPINs) and 90 clinically localized prostate cancers, were evaluated by immunohistochemical staining. p-Akt and p-mTOR ratios, which were defined as the expression level of p-Akt in relation to that of Akt and the expression level of p-mTOR in relation to that of mTOR, respectively, in these specimens were calculated. Results: Expression levels of all four molecules, including Akt, p-Akt, mTOR and p-mTOR, were significantly greater in the HGPIN group compared with the normal control and prostate cancer groups. Furthermore, the p-Akt ratio in the prostate cancer group was significantly lower than that in the HGPIN group, while there was no significant difference in the p-mTOR ratio between the HGPIN and prostate cancer groups. In the prostate cancer group, no significant relationships were observed between major clinicopathological parameters and the expression levels as well as the ratios of p-Akt or p-mTOR. Conclusions: The Akt-mTOR signaling pathway may play a limited role in the progression of prostate cancer.

Original languageEnglish
Pages (from-to)146-151
Number of pages6
JournalUrologia Internationalis
Volume93
Issue number2
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Sirolimus
Prostatic Neoplasms
Prostatic Intraepithelial Neoplasia
Prostate
Staining and Labeling

Keywords

  • Akt
  • High-grade prostatic intraepithelial neoplasia
  • Mammalian target of rapamycin
  • Prostate cancer

ASJC Scopus subject areas

  • Urology
  • Medicine(all)

Cite this

Limited significance of activated akt-mammalian target of rapamycin signaling pathway in prostate cancer progression. / Ko, Young Hwii; Miyake, Hideaki; Behnsawy, Hosny M.; Cheon, Jun; Fujisawa, Masato.

In: Urologia Internationalis, Vol. 93, No. 2, 01.01.2014, p. 146-151.

Research output: Contribution to journalArticle

Ko, Young Hwii ; Miyake, Hideaki ; Behnsawy, Hosny M. ; Cheon, Jun ; Fujisawa, Masato. / Limited significance of activated akt-mammalian target of rapamycin signaling pathway in prostate cancer progression. In: Urologia Internationalis. 2014 ; Vol. 93, No. 2. pp. 146-151.
@article{f2418759ace0402998e6f5c469634a62,
title = "Limited significance of activated akt-mammalian target of rapamycin signaling pathway in prostate cancer progression",
abstract = "Objective: The objective of this study was to investigate the significance of the activated Akt-mammalian target of rapamycin (Akt-mTOR) signaling pathway in the progression of prostate cancer. Materials and Methods: The expression levels of Akt, phosphorylated Akt (p-Akt), mTOR and phosphorylated mTOR (p-mTOR) in 175 prostate specimens, including 61 normal prostate tissues as a control, 24 high-grade prostatic intraepithelial neoplasias (HGPINs) and 90 clinically localized prostate cancers, were evaluated by immunohistochemical staining. p-Akt and p-mTOR ratios, which were defined as the expression level of p-Akt in relation to that of Akt and the expression level of p-mTOR in relation to that of mTOR, respectively, in these specimens were calculated. Results: Expression levels of all four molecules, including Akt, p-Akt, mTOR and p-mTOR, were significantly greater in the HGPIN group compared with the normal control and prostate cancer groups. Furthermore, the p-Akt ratio in the prostate cancer group was significantly lower than that in the HGPIN group, while there was no significant difference in the p-mTOR ratio between the HGPIN and prostate cancer groups. In the prostate cancer group, no significant relationships were observed between major clinicopathological parameters and the expression levels as well as the ratios of p-Akt or p-mTOR. Conclusions: The Akt-mTOR signaling pathway may play a limited role in the progression of prostate cancer.",
keywords = "Akt, High-grade prostatic intraepithelial neoplasia, Mammalian target of rapamycin, Prostate cancer",
author = "Ko, {Young Hwii} and Hideaki Miyake and Behnsawy, {Hosny M.} and Jun Cheon and Masato Fujisawa",
year = "2014",
month = "1",
day = "1",
doi = "10.1159/000356262",
language = "English",
volume = "93",
pages = "146--151",
journal = "Urologia Internationalis",
issn = "0042-1138",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Limited significance of activated akt-mammalian target of rapamycin signaling pathway in prostate cancer progression

AU - Ko, Young Hwii

AU - Miyake, Hideaki

AU - Behnsawy, Hosny M.

AU - Cheon, Jun

AU - Fujisawa, Masato

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: The objective of this study was to investigate the significance of the activated Akt-mammalian target of rapamycin (Akt-mTOR) signaling pathway in the progression of prostate cancer. Materials and Methods: The expression levels of Akt, phosphorylated Akt (p-Akt), mTOR and phosphorylated mTOR (p-mTOR) in 175 prostate specimens, including 61 normal prostate tissues as a control, 24 high-grade prostatic intraepithelial neoplasias (HGPINs) and 90 clinically localized prostate cancers, were evaluated by immunohistochemical staining. p-Akt and p-mTOR ratios, which were defined as the expression level of p-Akt in relation to that of Akt and the expression level of p-mTOR in relation to that of mTOR, respectively, in these specimens were calculated. Results: Expression levels of all four molecules, including Akt, p-Akt, mTOR and p-mTOR, were significantly greater in the HGPIN group compared with the normal control and prostate cancer groups. Furthermore, the p-Akt ratio in the prostate cancer group was significantly lower than that in the HGPIN group, while there was no significant difference in the p-mTOR ratio between the HGPIN and prostate cancer groups. In the prostate cancer group, no significant relationships were observed between major clinicopathological parameters and the expression levels as well as the ratios of p-Akt or p-mTOR. Conclusions: The Akt-mTOR signaling pathway may play a limited role in the progression of prostate cancer.

AB - Objective: The objective of this study was to investigate the significance of the activated Akt-mammalian target of rapamycin (Akt-mTOR) signaling pathway in the progression of prostate cancer. Materials and Methods: The expression levels of Akt, phosphorylated Akt (p-Akt), mTOR and phosphorylated mTOR (p-mTOR) in 175 prostate specimens, including 61 normal prostate tissues as a control, 24 high-grade prostatic intraepithelial neoplasias (HGPINs) and 90 clinically localized prostate cancers, were evaluated by immunohistochemical staining. p-Akt and p-mTOR ratios, which were defined as the expression level of p-Akt in relation to that of Akt and the expression level of p-mTOR in relation to that of mTOR, respectively, in these specimens were calculated. Results: Expression levels of all four molecules, including Akt, p-Akt, mTOR and p-mTOR, were significantly greater in the HGPIN group compared with the normal control and prostate cancer groups. Furthermore, the p-Akt ratio in the prostate cancer group was significantly lower than that in the HGPIN group, while there was no significant difference in the p-mTOR ratio between the HGPIN and prostate cancer groups. In the prostate cancer group, no significant relationships were observed between major clinicopathological parameters and the expression levels as well as the ratios of p-Akt or p-mTOR. Conclusions: The Akt-mTOR signaling pathway may play a limited role in the progression of prostate cancer.

KW - Akt

KW - High-grade prostatic intraepithelial neoplasia

KW - Mammalian target of rapamycin

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84927954766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927954766&partnerID=8YFLogxK

U2 - 10.1159/000356262

DO - 10.1159/000356262

M3 - Article

C2 - 24556942

AN - SCOPUS:84927954766

VL - 93

SP - 146

EP - 151

JO - Urologia Internationalis

JF - Urologia Internationalis

SN - 0042-1138

IS - 2

ER -